TransMedics Group, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2025: USD 49.38 M

TransMedics Group, Inc. Operating Cash Flow is USD 49.38 M for the Trailing 12 Months (TTM) ending March 31, 2025, a -732.95% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
  • TransMedics Group, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2024 was USD -7.80 M, a -78.37% change year over year.
  • TransMedics Group, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2023 was USD -36.07 M, a -9.68% change year over year.
  • TransMedics Group, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2022 was USD -39.94 M, a 35.76% change year over year.
  • TransMedics Group, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2021 was USD -29.42 M, a -11.38% change year over year.
Key Data
Date Operating Cash Flow Capital Expenditure Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities